Delivery Order SPE2DB20D1100-SPE2DB22FD6Y4
Award Date 9/29/22
Potential Completion Date 10/21/22
Potential Value $262K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>The Defense Logistics Agency Troop Support Medical (DOD - DLA) awarded a $437,238.00 delivery order contract to Amerisourcebergen Drug Corporation Corporate Office Division to provide 4558105410 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The contract has a place of performance in Conshohocken, Pennsylvania and runs from August 15, 2022 through September 6, 2022. The pricing for this firm fixed price contract was set at award. No subcontractors were identified.</p>
- <p>The Defense Logistics Agency Troop Support Medical awarded a $294,043.36 firm fixed price delivery order contract to Amerisourcebergen Drug Corporation for the provision of 4560239678 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The place of performance will be in Conshohocken, Pennsylvania and the period of performance is from March 13, 2023 through April 3, 2023. No applicable subcontractors were identified.</p>
- The Defense Logistics Agency issued a $128,188.50 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for Ocrevus 300 mg/10 ml vials under a firm fixed-price structure with a completion date of May 18, 2026. Place of performance is Conshohocken, PA. Amerisourcebergen is a pharmaceutical distributor and medical supplier operating as a subsidiary of Cencora, Inc., competing on a full and open basis without set-asides. The order supports pharmaceutical supply to federal healthcare...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of OCREVUS 300 mg/10 ml vials. The total potential value of the award is $128,918.52, with a completion date of October 15, 2021. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal contract awards from DLA to provide pharmaceuticals, medical supplies, and...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $45,237.44 to Amerisourcebergen Drug Corporation for the supply of 4562055207 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania under a start date of September 5, 2023 concluding on September 26, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The...
- <p>The Defense Logistics Agency issued a $25,637.70 delivery order to Amerisourcebergen Drug Corp on April 27, 2026, for Ocrevus 300 mg/10 ml vials.</p> <p>Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure and an ultimate completion date of May 18, 2026. No set-aside applied to this issuance.</p>
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 300 mg/10 ml vials of the pharmaceutical product OCREVUS. The $107,432.10 contract has a completion date of December 8, 2021 and was awarded on November 16, 2021. Amerisourcebergen Drug Corp has provided a range of pharmaceutical products and medical supplies to support Defense Logistics Agency programs. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of OCREVUS 300 mg/10 mL vials. This firm fixed-price contract, valued at approximately $70.8K, represents a competitive award with no set-aside designation and is scheduled for completion by December 9, 2025. AmerisourceBergen will fulfill this order from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $120,192.80, is for the delivery of OCREVUS 300 MG/10 ML VIAL 10ML, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
- <p>The Defense Logistics Agency issued a $38,456.55 delivery order to Amerisourcebergen Drug Corp on February 27, 2026, for Ocrevus 300 mg/10 mL vial (10 mL) under a firm fixed-price contract. Ultimate completion date is March 20, 2026. Place of performance is Conshohocken, PA.</p>
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB22FD6Y4Delivery Order
The Defense Logistics Agency (DOD) awarded a $262,342.80 firm fixed price delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division to provide 4558639319 OCREVUS 300 MG/10 ML VIAL 10ML pharmaceutical products. The place of performance will be in Conshohocken, Pennsylvania and the period of performance is from September 29, 2022 through October 21, 2022. No applicable subcontractors were identified.
Generated 11/28/23, 6:59 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $262.3k | 9/29/22 |